Most Read Articles
Stephen Padilla, 19 Jul 2019
A quadruple combination antiretroviral therapy (cART) demonstrates similar effects when compared to a triple cART in treatment-naïve people with HIV, according to the results of a systematic review and meta-analysis.
Jairia Dela Cruz, 01 Jun 2020
Current three-drug combination antiretroviral therapy (ART) regimens have proven to be highly effective, and the use of the relatively inexpensive rilpivirine (RPV) appears to have considerably better tolerability profile than efavirenz or protease inhibitors in regimens containing abacavir plus lamivudine (ABC/3TC) for treatment-naïve patients, offering a good, less costly approach to suppressing HIV, as shown in a Singapore study.
05 Jun 2020
Darunavir lacks potent in vitro antiviral activity against SARS-CoV-2 and is therefore not supported for use in the treatment of COVID-19, according to a recent study.
Audrey Abella, 05 May 2020
Use of the investigational drug fostemsavir, a prodrug of the first-in-class HIV-1 attachment inhibitor temsavir, led to a significant reduction in the HIV-1 RNA* level of adults with multidrug-resistant HIV-1 infection with limited antiretroviral therapy (ART) options, according to the results of the ongoing phase III BRIGHTE** trial.

Facial Skin Care (Patient Counselling Guide)

05 Jun 2020
Skin, being the most exposed part of the body, requires proper care. Skin ailments are common occurrence although they rarely tend to be serious and life threatening. Still, these conditions, especially those concerning the face, may have negative effects on the patient. It mostly affects the social and physiological well-being of a person. Common facial skin conditions that must be given attention to include acne, wrinkles, freckles, whiteheads and blackheads.

* Click below to view Patient Counselling Guide in Thai
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 19 Jul 2019
A quadruple combination antiretroviral therapy (cART) demonstrates similar effects when compared to a triple cART in treatment-naïve people with HIV, according to the results of a systematic review and meta-analysis.
Jairia Dela Cruz, 01 Jun 2020
Current three-drug combination antiretroviral therapy (ART) regimens have proven to be highly effective, and the use of the relatively inexpensive rilpivirine (RPV) appears to have considerably better tolerability profile than efavirenz or protease inhibitors in regimens containing abacavir plus lamivudine (ABC/3TC) for treatment-naïve patients, offering a good, less costly approach to suppressing HIV, as shown in a Singapore study.
05 Jun 2020
Darunavir lacks potent in vitro antiviral activity against SARS-CoV-2 and is therefore not supported for use in the treatment of COVID-19, according to a recent study.
Audrey Abella, 05 May 2020
Use of the investigational drug fostemsavir, a prodrug of the first-in-class HIV-1 attachment inhibitor temsavir, led to a significant reduction in the HIV-1 RNA* level of adults with multidrug-resistant HIV-1 infection with limited antiretroviral therapy (ART) options, according to the results of the ongoing phase III BRIGHTE** trial.